BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20067365)

  • 1. A one-step modified method to reduce the burst initial release from PLGA microspheres.
    Zheng C; Liang W
    Drug Deliv; 2010 Feb; 17(2):77-82. PubMed ID: 20067365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
    Zheng CH; Gao JQ; Zhang YP; Liang WQ
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1321-7. PubMed ID: 15451441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S; Kruenate J; Prahsarn C
    Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of alginate-chitosan-poly (lactic-co-glycolic acid) composite microsphere and its regulation of protein release].
    Zheng CH; Liang WQ; Yu HY
    Yao Xue Xue Bao; 2005 Feb; 40(2):182-6. PubMed ID: 15875679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication and evaluation of a sustained-release chitosan-based scaffold embedded with PLGA microspheres.
    Song K; Liu Y; Macedo HM; Jiang L; Li C; Mei G; Liu T
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1506-13. PubMed ID: 23827602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH; Taluja A; Knutson K; Han Bae Y
    J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery.
    Lee J; Oh YJ; Lee SK; Lee KY
    J Control Release; 2010 Aug; 146(1):61-7. PubMed ID: 20553775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F; Zhang ZR; Huang Y
    Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system.
    Choi DH; Park CH; Kim IH; Chun HJ; Park K; Han DK
    J Control Release; 2010 Oct; 147(2):193-201. PubMed ID: 20647022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of furosemide-loaded alginate microspheres prepared by ionotropic external gelation technique.
    Das MK; Senapati PC
    Acta Pol Pharm; 2007; 64(3):253-62. PubMed ID: 17695149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique.
    Wells LA; Sheardown H
    Eur J Pharm Biopharm; 2007 Mar; 65(3):329-35. PubMed ID: 17156984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel composite microparticles for protein stabilization and delivery.
    Schoubben A; Blasi P; Giovagnoli S; Perioli L; Rossi C; Ricci M
    Eur J Pharm Sci; 2009 Feb; 36(2-3):226-34. PubMed ID: 18950709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein micro and nanoencapsulation within glycol-chitosan/Ca²+/alginate matrix by spray drying.
    Erdinc B; Neufeld RJ
    Drug Dev Ind Pharm; 2011 Jun; 37(6):619-27. PubMed ID: 21449696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases.
    Rassu G; Salis A; Porcu EP; Giunchedi P; Roldo M; Gavini E
    Carbohydr Polym; 2016 Jan; 136():1338-47. PubMed ID: 26572479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long acting porous microparticle for pulmonary protein delivery.
    Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES
    Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system.
    Hu C; Feng H; Zhu C
    Colloids Surf B Biointerfaces; 2012 Jun; 95():162-9. PubMed ID: 22424828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres.
    Wang Y; Gao JQ; Chen HL; Zheng CH; Liang WQ
    Pharmazie; 2006 Apr; 61(4):367-8. PubMed ID: 16649559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative three-dimensional analysis of poly (lactic-co-glycolic acid) microsphere using hard X-ray nano-tomography revealed correlation between structural parameters and drug burst release.
    Huang X; Li N; Wang D; Luo Y; Wu Z; Guo Z; Jin Q; Liu Z; Huang Y; Zhang Y; Wu C
    J Pharm Biomed Anal; 2015 Aug; 112():43-9. PubMed ID: 25951620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles.
    Manca ML; Loy G; Zaru M; Fadda AM; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2008 Dec; 67(2):166-70. PubMed ID: 18835764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.